Page last updated: 2024-10-24

chlorambucil and Cancer, Second Primary

chlorambucil has been researched along with Cancer, Second Primary in 26 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Between 1976 and 1984, 574 patients with operable breast cancer and histologically negative axillary lymph nodes were randomly assigned after mastectomy to receive either no further treatment or chemotherapy with oral LMF (fluorouracil, 500 mg, methotrexate, 25 mg, and chlorambucil, 10 mg, on day 1; fluorouracil, 500 mg, and chlorambucil, 10 mg, on day 2)."5.07West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer. ( Grieve, RJ; Howell, A; Kelly, KA; Monypenny, IJ; Morrison, JM; Walker, RA; Waterhouse, JA, 1992)
"Patients with chronic lymphocytic leukemia (CLL) may have disease transformation to non-Hodgkin's lymphoma or prolymphocytic leukemia; however, development of therapy-related acute myeloid leukemia (t-AML) is unusual."2.70Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. ( Appelbaum, FR; Elias, L; Hines, JD; Kolitz, JE; Larson, RA; Morrison, VA; Peterson, BL; Rai, KR; Schiffer, CA; Shepherd, L, 2002)
"Localized MALT lymphomas have excellent prognosis following moderate-dose RT."1.31Stage I and II MALT lymphoma: results of treatment with radiotherapy. ( Bezjak, A; Crump, M; Gospodarowicz, MK; Hodgson, DC; Pintilie, M; Tsang, RW; Wells, W, 2001)
"The relative risk of second cancers overall was 27."1.30Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. ( Barber, JA; Cunningham, D; Horwich, A; Milan, S; Omar, RZ; Swerdlow, AJ, 1997)
"Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy."1.30High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999)
"Thirteen patients have died of their second malignancy, including two of a third malignancy, while four have been followed for less than one year."1.29Second malignant neoplasms in patients with Hodgkin's disease. ( Atkinson, CH; Colls, BM; Fitzharris, BM; Robinson, BA, 1994)
"2846 patients first treated for Hodgkin's disease during 1970-87, for whom follow up was complete in 99."1.28Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. ( Bennett, MH; Douglas, AJ; Hudson, BV; Hudson, GV; MacLennan, KA; Swerdlow, AJ, 1992)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (42.31)18.2507
2000's7 (26.92)29.6817
2010's7 (26.92)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
da Cunha-Bang, C1
Rostgaard, K1
Andersen, MA1
Rotbain, EC1
Grønbaek, K1
Frederiksen, H1
Niemann, CU1
Hjalgrim, H1
Hangül, C1
Yücel, OK1
Akkaya, B1
Ündar, L1
Berker Karaüzüm, S1
Streu, E1
Barzenje, DA1
Cvancarova Småstuen, M1
Liestøl, K1
Fosså, A1
Delabie, J1
Kolstad, A1
Holte, H1
Vidal, L1
Gurion, R1
Ram, R1
Raanani, P1
Bairey, O1
Robak, T1
Gafter-Gvili, A1
Shpilberg, O1
Maurer, C1
Langerbeins, P1
Bahlo, J1
Cramer, P1
Fink, AM1
Pflug, N1
Engelke, A1
von Tresckow, J1
Kovacs, G1
Stilgenbauer, S1
Wendtner, CM1
Müller, L1
Ritgen, M1
Seiler, T1
Fischer, K1
Hallek, M1
Eichhorst, B1
Mirabile, A1
Devizzi, L1
Gianni, AM1
Cabras, A1
Carbone, A1
Breton, AL1
Poulalhon, N1
Balme, B1
Thomas, L1
Dalle, S1
Morrison, VA1
Rai, KR1
Peterson, BL1
Kolitz, JE1
Elias, L1
Appelbaum, FR1
Hines, JD1
Shepherd, L1
Larson, RA1
Schiffer, CA1
Metayer, C1
Curtis, RE1
Vose, J1
Sobocinski, KA1
Horowitz, MM1
Bhatia, S1
Fay, JW1
Freytes, CO1
Goldstein, SC1
Herzig, RH1
Keating, A1
Miller, CB1
Nevill, TJ1
Pecora, AL1
Rizzo, JD1
Williams, SF1
Li, CY1
Travis, LB1
Weisdorf, DJ1
Martinelli, G1
Cocorocchio, E1
Peccatori, F1
Zucca, E1
Saletti, PC1
Calabrese, L1
Pastano, R1
Pruneri, G1
Mazzetta, C1
Ghielmini, M1
Cavalli, F1
Callea, V1
Brugiatelli, M1
Stelitano, C1
Gentile, M1
Nobile, F1
Morabito, F1
Capra, M1
Hewitt, M1
Radford, M1
Hayward, J1
Weston, CL1
Machin, D1
Kelsey, SM1
Newland, AC2
Hudson, GV3
Jelliffe, AM1
Robinson, BA1
Colls, BM1
Fitzharris, BM1
Atkinson, CH1
Swerdlow, AJ2
Barber, JA1
Horwich, A1
Cunningham, D1
Milan, S1
Omar, RZ1
Morita, K1
Mizuno, T1
Tanaka, I2
Suzuki, H1
Miwa, H1
Nishikawa, M1
Kita, K1
Shiku, H1
Harrison, CN1
Gregory, W1
Devereux, S1
Goldstone, AH1
Hancock, B1
Winfield, D1
MacMillan, AK1
Hoskin, P1
Milligan, D1
Linch, DC1
Calvo Villas, J1
Ramírez Sánchez, M1
Sicilia Guillén, F1
Tsang, RW1
Gospodarowicz, MK1
Pintilie, M1
Bezjak, A1
Wells, W1
Hodgson, DC1
Crump, M1
Radford, JA1
Rohatiner, AZ1
Ryder, WD1
Deakin, DP1
Barbui, T1
Lucie, NP1
Rossi, A1
Dunlop, DJ1
Cowan, RA1
Wilkinson, PM1
Gupta, RK1
James, RD1
Shamash, J1
Chang, J1
Crowther, D1
Lister, TA1
Majado, MJ1
González García, C1
Marín-Blazquez, MD1
Morales Lázaro, A1
Moreno Moreno, M1
Avilés, A1
Díaz-Maqueo, JC1
Ayala, JR1
Cortés, HD1
García, EL1
Douglas, AJ1
Hudson, BV1
Bennett, MH1
MacLennan, KA1
Dedrick, RL1
Morrison, PF1
Morrison, JM1
Kelly, KA1
Howell, A1
Grieve, RJ1
Monypenny, IJ1
Walker, RA1
Waterhouse, JA1

Reviews

2 reviews available for chlorambucil and Cancer, Second Primary

ArticleYear
Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:9

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dis

2016
Primary cutaneous marginal zone lymphoma as a complication of radiation therapy: Case report and review.
    Dermatology online journal, 2010, Dec-15, Volume: 16, Issue:12

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Hormonal; Antineoplastic Combin

2010

Trials

5 trials available for chlorambucil and Cancer, Second Primary

ArticleYear
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
    Leukemia, 2016, Volume: 30, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Bendamustine Hydrochloride; Case-Control Studies; Cell Transformatio

2016
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Sep-15, Volume: 20, Issue:18

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chlorambuci

2002
A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma.
    Medical oncology (Northwood, London, England), 1994, Volume: 11, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Chlorambucil; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgk

1994
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cy

2002
West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.
    Journal of the National Cancer Institute. Monographs, 1992, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chlorambuc

1992

Other Studies

19 other studies available for chlorambucil and Cancer, Second Primary

ArticleYear
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
    British journal of haematology, 2021, Volume: 193, Issue:2

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Chloramb

2021
The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2019, May-03, Volume: 36, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dexamethasone; Humans; Leukemia,

2019
Second malignancies in chronic lymphocytic leukemia.
    Oncology nursing forum, 2014, Jan-01, Volume: 41, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin

2014
Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiova

2015
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents,

2010
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
    Blood, 2003, Mar-01, Volume: 101, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth

2003
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.
    British journal of haematology, 2004, Volume: 125, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Di

2004
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorambucil; Female; Humans; Incidence; Leuk

2006
Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
    European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; D

2007
Second malignant neoplasms in patients with Hodgkin's disease.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda

1994
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
    British journal of cancer, 1997, Volume: 75, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

1997
[Acute myelogenous leukemia (M4) occurring during chronic lymphocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Estradiol; Etoposide; Humans; Le

1997
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    British journal of cancer, 1999, Volume: 81, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine;

1999
[Chronic lymphatic leukemia and Hodgkin's disease].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; F

1999
Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    International journal of radiation oncology, biology, physics, 2001, Aug-01, Volume: 50, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Co

2001
[Appearance of a chronic myeloid leukemia in Waldenström's macroglobulinemia].
    Sangre, 1992, Volume: 37, Issue:6

    Topics: Busulfan; Chlorambucil; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged;

1992
Hodgkin's disease and acute leukemia. Is it a true association?
    Archives of medical research, 1992,Spring, Volume: 23, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil

1992
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    BMJ (Clinical research ed.), 1992, May-02, Volume: 304, Issue:6835

    Topics: Adolescent; Adult; Alkylating Agents; Child; Chlorambucil; Cohort Studies; Female; Follow-Up Studies

1992
Carcinogenic potency of alkylating agents in rodents and humans.
    Cancer research, 1992, May-01, Volume: 52, Issue:9

    Topics: Animals; Carcinogenicity Tests; Chlorambucil; Cyclophosphamide; Humans; Melphalan; Mice; Neoplasms,

1992